ClinicalTrials.gov
public full text
Public Domain
Concurrent Chemo-radiation Form NSCLC to a Individualized MLD
Our group has shown in a modeling study that increasing the radiation dose to pre-specified normal tissue dose constrains could lead to increased TCP with the same NTCP in patients with non-concurrent chemo-radiation. In a subsequent phase I trial, in patients receiving non-concurrent chemo-radiation we showed the safety of this approach. Here,we want to investigate its efficacy in a prospective study in patients with stage III NSCLC, who are selected for radical concurrent radiotherapy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Radiation Dose Escalation in Locally Advanced Rectal Cancer#1046741
- Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC#856195
- Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC#836680
- Time Trends in Waiting Times of NSCLC Patients.#1153313
- Higher Radiation Dose to the Tumor May Help Avoid Surgery in Rectal Cancer Patients#850285
Record · ID 847621
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive